Skip to content

Rapid Response D3.4-1G29

by BTNX Inc

Rapid Response D3.4-1G29 is a Class II device made by BTNX Inc, cleared under FDA 510(k) K161044 on 6 Jul 2016 and listed in FDA GUDID since 3 Jun 2020 (UDI-DI 10722066005139), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K161044

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10722066005139 UDI-DI Date3 Jun 2020ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK161044 Date6 Jul 2016DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K161044 decided 6 Jul 2016 Active
  • FDA GUDID UDI-DI 10722066005139 listed 3 Jun 2020 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K161044
  2. Listed FDA GUDID 10722066005139

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Rapid Response
Generic name
Multiple drugs of abuse IVD, kit, rapid ICT, clinical
Model / reference
D3.4-1G29
Primary DI / UDI-DI
10722066005139
510(k) Number
FDA product code
DIO, LDJ, DJC
GMDN term
Multiple drugs of abuse IVD, kit, rapid ICT, clinical
Device class
Class II
Regulation number
862.3250, 862.3870, 862.3610
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Multiple drugs of abuse IVD, kit, rapid ICT, clinical.

Other devices from BTNX Inc

See all devices from BTNX Inc →

Properties

  • Single use
  • Prescription use
  • Over-the-counter
  • Lot / batch number
  • Expiration date
Other properties (10, all answered No)